CN1290551C - Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone - Google Patents

Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone Download PDF

Info

Publication number
CN1290551C
CN1290551C CN 200410004720 CN200410004720A CN1290551C CN 1290551 C CN1290551 C CN 1290551C CN 200410004720 CN200410004720 CN 200410004720 CN 200410004720 A CN200410004720 A CN 200410004720A CN 1290551 C CN1290551 C CN 1290551C
Authority
CN
China
Prior art keywords
portions
radix
chinese medicine
raw material
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200410004720
Other languages
Chinese (zh)
Other versions
CN1660152A (en
Inventor
司创
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410004720 priority Critical patent/CN1290551C/en
Publication of CN1660152A publication Critical patent/CN1660152A/en
Application granted granted Critical
Publication of CN1290551C publication Critical patent/CN1290551C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine composition for treating rheumatism, rheumatoid arthritis, neck pain, shoulder pain, waist pain, leg pain, hyperosteogeny or acroanesthesia. The present invention comprises the following raw materials by weight portion: 50 to 150 portions of orientvine stem, 50 to 150 portions of pangolin, 50 to 150 portions of scorpion, 50 to 150 portions of honeycomb, 50 to 150 portions of centipede, 50 to 150 portions of rehmannia root, 50 to 150 portions of Chinese angelica, 50 to 150 portions of spatholobus stem, 10 to 200 portions of licorice root, 10 to 100 portions of white mustard seed, 50 to 150 portions of epimedium, 50 to 150 portions of black snake, 50 to 150 portions of earthworm, 50 to 150 portions of ground beetle, 50 to 150 portions of pyrola herb, 50 to 150 portions of pulp of dogwood fruit and 10 to 60 portions of dragon blood.

Description

A kind of Chinese medicine composition that is used for invigorating the kidney and strengthening the bones
Invention field
The present invention relates to a kind of invigorating the kidney and strengthening the bones that is used for, be particularly useful for treating rheumatism, rheumatoid arthritis, neck, shoulder, lumbago and skelalgia, hyperosteogeny, the Chinese medicine composition of numb limbs and tense tendons.
Background technology
Rheumatism, rheumatoid, hyperosteogeny, neck, shoulder, lumbago and skelalgia etc. all belong to the category of traditional Chinese medical science arthromyodynia.It is many that insufficiency of vital energy and blood adds due to the damp that is affected by the cold because of suffering from a deficiency of the kidney, course of disease delay, and prolonged difficulty has more been brought great misery to the patient.Rheumatism, rheumatoid disease involve periarticular soft tissues and cartilage more, and affected part pain and swelling, even joint deformity, severe patient are taken care of oneself limited with ability to work.Chinese patent medicine and Western medicine that many these diseases of treatment are arranged in the market, but curative effect still remains to be improved.The inventor is engaged in tcm clinical practice work for a long time, has developed a kind of Chinese prescription for the treatment of these diseases, and constantly test and improvement on this basis, has obtained very encouraging result.Thus, finished the present invention.
Summary of the invention
Therefore, the objective of the invention is to overcome the deficiencies in the prior art, a kind of rheumatism of extremely effectively treating is provided, rheumatoid arthritis, neck, shoulder, lumbago and skelalgia, hyperosteogeny, numb Chinese medicine composition.
Compositions of the present invention comprises following raw material by weight:
Caulis Sinomenii 50-150 Squama Manis 50-150 Scorpio 50-150
Nidus Vespae 50-150 Scolopendra 50-150 Radix Rehmanniae 50-150
Radix Angelicae Sinensis 50-150 Caulis Spatholobi 50-150 Radix Glycyrrhizae 10-200
Semen Sinapis Albae 10-100 Herba Epimedii 50-150 Zaocys 50-150
Pheretima 50-150 eupolyphaga 50-150 Herba Pyrolae 50-150
Fructus Corni 50-150 Sanguis Draxonis 10-60.
The preferred weight proportioning of each raw material of compositions of the present invention is:
Caulis Sinomenii 100 Squama Maniss 100 Scorpios 100
Nidus Vespae 100 Scolopendras 100 Radix Rehmanniae 100
Radix Angelicae Sinensis 100 Caulis Spatholobis 100 Radix Glycyrrhizaes 30
Semen Sinapis Albae 30 Herba Epimedii 100 Zaocyss 100
Pheretima 100 eupolyphaga 100 Herba Pyrolaes 100
Fructus Corni 100 Sanguis Draxonis 30.
Above-mentioned prescription has the kidney invigorating nourishing the liver, dispelling wind and removing obstruction in the collateral, and effects such as blood circulation promoting and blood stasis dispelling, the dispelling wind and removing obstruction in the collateral effect of dissolving stasis and relieving pain is extremely strong, and its efficacy of a drug is high violent, makes that for a long time long-pending intravital wind-cold damp pathogen is dispeled.
Pharmaceutical composition of the present invention can be used as medicine with raw material, and perhaps the effective ingredient that extracts with its any method (comprise water propose organic solvent extraction, liquid chromatography technology extraction etc.) is used as medicine.Can compositions of the present invention be made any dosage form that is suitable for clinically, for example honeyed pill, the watered pill, capsule, powder, tablet, oral liquid, concentrated pill, granule, electuary, medicine for external use etc. according to conventional preparation technology.Preferred dosage form is the watered pill, concentrated pill, capsule etc.
For example, each raw material of compositions of the present invention can be ground into powder, mix homogeneously is made the watered pill with controlling the water circulation ball machine, or directly incapsulates and make capsule.
The raw material water of compositions of the present invention can also be decocted one or many, after the filtration, make oral liquid.
The raw material water of compositions of the present invention can also be decocted one or many, concentrating under reduced pressure becomes fluid extract, and oven dry is pulverized, and granulates, and makes concentrated pill.
Because there is certain toxicity in part medicine of the present invention, so the day dosage of medicine of the present invention is generally 10-30g, preferred 12-20g (by the gross weight of giving birth to crude drug), (for example 2-3 time) administration one or more times.Child's consumption cuts down according to the circumstance.
The specific embodiment
Illustrate the present invention by the following examples.
Embodiment 1
Caulis Sinomenii 100g Squama Manis 100g Scorpio 100g
Nidus Vespae 100g Scolopendra 100g Radix Rehmanniae Preparata 100g
Radix Angelicae Sinensis 100g Caulis Spatholobi 100g Radix Glycyrrhizae 30g
Semen Sinapis Albae 30g Herba Epimedii 100g Zaocys 100g
Pheretima 100g eupolyphaga 100g Herba Pyrolae 100g
Fructus Corni 100g Sanguis Draxonis 30g
Above-mentioned raw materials is cleaned, air-dry, be crushed to 100 orders, remix is even, makes the watered pill with controlling the water circulation ball machine, sooner or later respectively obeys 8g, and two months is a course of treatment.
Embodiment 2
Caulis Sinomenii 120g Squama Manis 90g Scorpio 110g
Nidus Vespae 115g Scolopendra 100g Radix Rehmanniae Preparata 100g
Radix Angelicae Sinensis 100g Caulis Spatholobi 100g Radix Glycyrrhizae 30g
Semen Sinapis Albae 30g Herba Epimedii 100g Zaocys 80g
Pheretima 100g eupolyphaga 120g Herba Pyrolae 100g
Fructus Corni 100g Sanguis Draxonis 30g
Above-mentioned raw materials is cleaned, air-dry, be crushed to 100, remix is even, incapsulates, and makes capsule, sooner or later respectively takes 8g, and 2 months is a course of treatment.
Embodiment 3
Caulis Sinomenii 100g Squama Manis 80g Scorpio 80g
Nidus Vespae 100g Scolopendra 70g Radix Rehmanniae Preparata 150g
Radix Angelicae Sinensis 100g Caulis Spatholobi 100g Radix Glycyrrhizae 150g
Semen Sinapis Albae 30g Herba Epimedii 100g Zaocys 60g
Pheretima 80g eupolyphaga 60g Herba Pyrolae 100g
Fructus Corni 120g Sanguis Draxonis 50g
Above-mentioned raw materials is shredded roughly, and the decocting that adds 8 times of amounts boils, and gets filtrate after the filtration, and residue decocts 2 times again, adds 6 times of water gagings at every turn, merges each time filtrate, is condensed into paste, and oven dry is pulverized, and granulates, and repress becomes tablet.
Embodiment 4
Caulis Sinomenii 100g Squama Manis 80g Scorpio 80g
Nidus Vespae 100g Scolopendra 70g Radix Rehmanniae Preparata 150g
Radix Angelicae Sinensis 100g Caulis Spatholobi 100g Radix Glycyrrhizae 150g
Semen Sinapis Albae 30g Herba Epimedii 100g Zaocys 60g
Pheretima 80g eupolyphaga 60g Herba Pyrolae 100g
Fructus Corni 120g Sanguis Draxonis 50g
Above-mentioned raw materials is shredded roughly, and the decocting that adds 8 times of amounts boils, and gets filtrate after the filtration, and residue decocts 2 times again, adds 6 times of water gagings at every turn, merges each time filtrate, makes oral liquid.
Clinical pharmacodynamics test
Inventor's medicine with the embodiment of the invention 1 in clinical has carried out clinical trial, and case adds up to 280 examples, and patient age is 14-76 year, male 116 examples, and women 164 examples, therapeutic outcome is as follows:
Table 1
Case load Produce effects Effectively Invalid Total effective rate
Rheumatism 122 107 15 0 100%
Rheumatoid 44 20 21 3 93.2%
Neck, shoulder, lumbago and skelalgia 76 51 24 1 98.7%
Hyperosteogeny 38 19 13 6 84.2%
Above result shows, medicine of the present invention is for rheumatism, rheumatoid, and neck, shoulder, lumbago and skelalgia, hyperosteogeny has extraordinary curative effect.

Claims (3)

1, a kind of treatment rheumatism, rheumatoid arthritis, neck, shoulder, lumbago and skelalgia, the Chinese medicine composition of hyperosteogeny or numb limbs and tense tendons, the raw material composition of making effective ingredient is by weight:
Caulis Sinomenii 50-150 Squama Manis 50-150 Scorpio 50-150
Nidus Vespae 50-150 Scolopendra 50-150 Radix Rehmanniae 50-150
Radix Angelicae Sinensis 50-150 Caulis Spatholobi 50-150 Radix Glycyrrhizae 10-200
Semen Sinapis Albae 10-100 Herba Epimedii 50-150 Zaocys 50-150
Pheretima 50-150 eupolyphaga 50-150 Herba Pyrolae 50-150
Fructus Corni 50-150 Sanguis Draxonis 10-60.
2, according to the Chinese medicine composition of claim 1, wherein the weight proportion of each raw material is:
Caulis Sinomenii 100 Squama Maniss 100 Scorpios 100
Nidus Vespae 100 Scolopendras 100 Radix Rehmanniae 100
Radix Angelicae Sinensis 100 Caulis Spatholobis 100 Radix Glycyrrhizaes 30
Semen Sinapis Albae 30 Herba Epimedii 100 Zaocyss 100
Pheretima 100 eupolyphaga 100 Herba Pyrolaes 100
Fructus Corni 100 Sanguis Draxonis 30.
3, prepare the method for the Chinese medicine composition of claim 1 or 2, comprise each raw material is ground into powder that mix homogeneously is made the watered pill.
CN 200410004720 2004-02-24 2004-02-24 Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone Expired - Fee Related CN1290551C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410004720 CN1290551C (en) 2004-02-24 2004-02-24 Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410004720 CN1290551C (en) 2004-02-24 2004-02-24 Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone

Publications (2)

Publication Number Publication Date
CN1660152A CN1660152A (en) 2005-08-31
CN1290551C true CN1290551C (en) 2006-12-20

Family

ID=35009891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410004720 Expired - Fee Related CN1290551C (en) 2004-02-24 2004-02-24 Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone

Country Status (1)

Country Link
CN (1) CN1290551C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961406B (en) * 2010-10-28 2012-05-23 李桂宾 Medicament for treating muscle and bone diseases caused by chronic infectious arthritis
CN103585350A (en) * 2013-11-28 2014-02-19 刘相英 Traditional Chinese medicine for treating rheumatism
CN104815056A (en) * 2015-03-28 2015-08-05 繁昌县智融中药材专业合作社 Externally used traditional Chinese medicine for treating rheumatoid arthritis

Also Published As

Publication number Publication date
CN1660152A (en) 2005-08-31

Similar Documents

Publication Publication Date Title
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN1857541A (en) Plaster for treating rheumatism and osteoarthrosis
CN1682982A (en) Yishenkangshuai pill for treating chronic nephrosis and renal failure
CN101530568B (en) Paralysis-expelling pain-relieving capsule
CN1814208A (en) Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN1868535A (en) Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method
CN104758659A (en) Traditional Chinese medicine paste for treating muscle and bone diseases
CN101703662B (en) Oral Chinese medicament for treating hyperosteogeny
CN1245173C (en) Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process
CN1290551C (en) Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone
CN1931277A (en) Osteoarthrosis treating Chinese medicine composition and its prepn process
CN101040949A (en) Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and apllication
CN1051471C (en) Drug composition for curing osteoporosis
CN101496838A (en) Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof
CN1283302C (en) Medicament for treating rheumatoid arthritis and artjritis pauperum
CN102370688A (en) Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof
CN1059594C (en) Chinese medicine Gutongning and its preparation
CN102406870A (en) Medicament for treating rheumatic arthralgia
CN1186067C (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN1443545A (en) Medicine for curing acne and its preparation method
CN101284087B (en) Medicinal composition for curing lumbar disease
CN1241626C (en) Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis
CN105770251A (en) Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis
CN1238021C (en) Medicine for treating osteoproliferation
CN103272095A (en) Dorsal disc prolapse treatment traditional Chinese medicine preparation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee